Tig Advisors, LLC Bristol Myers Squibb CO Transaction History

Tig Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$61.91 - $67.42 $11.4 Million - $12.4 Million	-184,622 Closed	0 $0
Q1 2021 May 18, 2021	SELL	$59.34 - $66.74 $19.7 Million - $22.2 Million	-332,805 Reduced 64.32%	184,622 $11.7 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $29.9 Million - $33.9 Million	517,427 New	517,427 $32.1 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $434 Million - $630 Million	-9,348,540 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $441 Million - $575 Million	8,965,102 Added 2338.08%	9,348,540 $28.1 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $17.3 Million - $20.6 Million	383,438 New	383,438 $18.3 Million

2,400

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Tig Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Tig Advisors, LLC with notifications on news.